|
Name |
Acetate
|
Molecular Formula | C2H3O2- | |
IUPAC Name* |
acetate
|
|
SMILES |
CC(=O)[O-]
|
|
InChI |
InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)/p-1
|
|
InChIKey |
QTBSBXVTEAMEQO-UHFFFAOYSA-M
|
|
Synonyms |
acetate; Acetate Ion; Acetic acid, ion(1-); 71-50-1; Acetate ions; Acetate anion; Acetoxy ion; Acetic acid anion; MeCO2 anion; ethanoate; Acetate ion (1-); 569DQM74SC; Natriumazetat; Ethanoat; Shotgun; monoacetate; CHEMBL1354; UNII-569DQM74SC; Azetat; racemic acetate; acetyl hydroxide; Acetic acid ion; Acetic cid glacial; ACETATE [VANDF]; CH3-COO(-); DTXSID1037694; CHEBI:30089; BDBM50159793; CMC_13391; STL282721; AKOS022101130; DB14511; Q9154808
|
|
CAS | 71-50-1 | |
PubChem CID | 175 | |
ChEMBL ID | CHEMBL1354 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 59.04 | ALogp: | 0.4 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 40.1 | Aromatic Rings: | 0 |
Heavy Atoms: | 4 | QED Weighted: | 0.369 |
Caco-2 Permeability: | -5.218 | MDCK Permeability: | 0.00216227 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.173 |
Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.002 |
Blood-Brain-Barrier Penetration (BBB): | 0.923 | Plasma Protein Binding (PPB): | 11.63% |
Volume Distribution (VD): | 0.323 | Fu: | 79.86% |
CYP1A2-inhibitor: | 0.021 | CYP1A2-substrate: | 0.101 |
CYP2C19-inhibitor: | 0.026 | CYP2C19-substrate: | 0.059 |
CYP2C9-inhibitor: | 0.004 | CYP2C9-substrate: | 0.284 |
CYP2D6-inhibitor: | 0.041 | CYP2D6-substrate: | 0.111 |
CYP3A4-inhibitor: | 0.015 | CYP3A4-substrate: | 0.047 |
Clearance (CL): | 1.609 | Half-life (T1/2): | 0.791 |
hERG Blockers: | 0.01 | Human Hepatotoxicity (H-HT): | 0.15 |
Drug-inuced Liver Injury (DILI): | 0.218 | AMES Toxicity: | 0.02 |
Rat Oral Acute Toxicity: | 0.037 | Maximum Recommended Daily Dose: | 0.013 |
Skin Sensitization: | 0.311 | Carcinogencity: | 0.033 |
Eye Corrosion: | 0.973 | Eye Irritation: | 0.942 |
Respiratory Toxicity: | 0.039 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000009 | 0.455 | D0Z4UY | 0.889 | ||||
ENC000288 | 0.357 | D0C1PY | 0.889 | ||||
ENC000713 | 0.357 | D0Z4NI | 0.471 | ||||
ENC000061 | 0.313 | D0F1GS | 0.471 | ||||
ENC000010 | 0.313 | D04CRL | 0.455 | ||||
ENC000015 | 0.286 | D02FLB | 0.417 | ||||
ENC000312 | 0.278 | D04UUH | 0.385 | ||||
ENC000058 | 0.267 | D00ZOF | 0.375 | ||||
ENC001900 | 0.259 | D0R9BG | 0.357 | ||||
ENC000403 | 0.250 | D0G4JI | 0.313 |